Effective January 1, 2026, Utah Medicaid is requiring that we align certain drug classes on our Medicaid managed care formulary with the Utah Medicaid Preferred Drug List (PDL). An initial 90-day transition period applied prior to January 1, 2026, for impacted members. We previously mailed you a patient list identifying members who may be affected, along with an email that includes the list of drug classes on the Medicaid Hybrid PDL.
On the formulary, impacted medications will now display either “Hybrid PDL Preferred” or “Hybrid PDL Non-Preferred” to indicate their status under the Medicaid Hybrid PDL.
Members who are new to the plan after January 1, 2026, and are taking non-preferred medications will follow the standard transition policy, which allows a single 30-day supply within the first 90 days of enrollment while the medication is transitioned to a preferred product or receives prior authorization.
The impacted preferred medication drug classes can be found here for Healthy U and here for Health Choice Utah.
